AOL Money & Finance

The Travelers: Undiscovered gem

More

In this market and economy it pays (literally) to have a few moderate-risk stocks in your portfolio that also have an chance for a decent upside.

The Travelers Companies (TRV), is one, and that's why I'm reiterating my by buy rating for the company, first recommended on April 24, 2009, at a price of $39.50. If you bought TRV in April, you're up about 34%.

Look for non-sexy insurer The Travelers to register earned premium growth of 1% to 3.5% in FY2010, compared to a likely statistically flat FY2009.

Meanwhile, investment income should increase 7% to 9% in FY2009, followed by a double-digit gain in FY2010.

Further, look for The Travelers' to continue to improve underwriting results and to capitalize on the flight-to-quality in property-casualty insurance market. And the surprising thing about the company's recent performance history this is that institutional investors (IIs) -- perhaps chasing higher returns in likely stronger-growth plays -- still haven't bid-up The Travelers' shares: a P/E of about 10 means TRV is still pretty cheap. If you didn't purchase shares in April, you have an opportunity to do so now, at an attractive price.

True, TRV may have to add to loss reserves for certain liability coverage lines, but the view from here argues that the above in no way deflects from the appeal of this superior, demonstrated, diversified insurance business model. The First Call FY2009/FY2010 EPS estimates for TRV are $5.63 to $5.63.

Techncially, The Travelers' stock chart is strong: since breaking out of a trading range in the summer, TRV has remained above the key, 50-day moving average, and the stock recently broke through psychological resistance at $50; 2-year resistance at/near $56 should prove to be minor.

Stock Analysis: The Travelers Companies is a moderate-risk stock. If you've already purchased the company's shares, hold them. If not, consider buying a 50% position in TRV now; then buy another 25% in one month, if U.S. and global economic conditions don't worsen substantially. Under any circumstance, don't buy more than 75% of your TRV position before December 2009. Sell/Stop Loss if you were to buy shares in this company: $22.

- -

Disclosure: Lazzaro has no positions in stocks, but does own shares in two Pimco Bond Funds: PHDAX and PYMAX.

Add your comments

Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.

When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.

Symbol Lookup
IndexesChangePrice
DJIA-14.2810,318.16
NASDAQ-10.782,146.04
S&P 500-3.521,091.38

Last updated: November 20, 2009: 06:53 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines